Immatics (IMTX) Short-Term Debt repayments (2022 - 2025)
Immatics' (IMTX) quarterly Short-Term Debt repayments came in at -$870704.5 in Q4 2025, down 3.93% year-on-year from -$906324.2 in Q4 2024, and down 0.92% quarter-over-quarter from -$862762.7 in Q3 2025.
Immatics (IMTX) Short-Term Debt repayments (2022 - 2025) Analysis & Trends
Immatics has disclosed Short-Term Debt repayments across 4 years of filings, most recently posting -$870704.5 for Q4 2025.
- Short-Term Debt repayments for Q4 2025 came in at -$870704.5, down 3.93% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.5 million (down 1549.35% YoY), and the FY2025 annual result was -$3.3 million, down 55.49% from the prior year.
- Short-Term Debt repayments came in at -$870704.5 for Q4 2025 at Immatics, down from -$862762.7 in the prior quarter.
- In the past five years, Short-Term Debt repayments ranged from a high of $3.1 million in Q4 2023 to a low of -$1.1 million in Q3 2023.
- The 4-year median for Short-Term Debt repayments is -$850270.7 (2024), against an average of -$542186.7.
- Across the five-year window, Short-Term Debt repayments surged 544.93% in 2023 and tumbled 127.1% in 2024, its largest moves.
- Immatics' Short-Term Debt repayments stood at -$694788.5 in 2022, then surged by 544.93% to $3.1 million in 2023, then tumbled by 127.1% to -$837778.8 in 2024, then fell by 3.93% to -$870704.5 in 2025.
- The last three Short-Term Debt repayments figures came in at -$870704.5 (Q4 2025), -$862762.7 (Q3 2025), and -$837778.8 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 102,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -482,347.21 |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -870,704.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -870,704.55 |
| Dec 31, 2025 | -870,704.55 |
| Sep 30, 2025 | -862,762.66 |
| Sep 30, 2025 | -862,762.66 |
| Dec 31, 2024 | -837,778.79 |
| Dec 31, 2024 | -837,778.79 |
| Sep 30, 2024 | -912,620.41 |
| Sep 30, 2024 | -912,620.41 |
| Dec 31, 2023 | 3.09 Mn |
| Dec 31, 2023 | 3.09 Mn |
| Sep 30, 2023 | -1.10 Mn |
| Sep 30, 2023 | -1.10 Mn |
| Jun 30, 2023 | -1.09 Mn |
| Jun 30, 2023 | -1.09 Mn |
| Mar 31, 2023 | -929,514.02 |
| Mar 31, 2023 | -929,514.02 |
| Dec 31, 2022 | -694,788.46 |
| Dec 31, 2022 | -694,788.46 |
| Sep 30, 2022 | -774,354.69 |
| Sep 30, 2022 | -774,354.69 |